San Jose, California — According to state and local economic development sources Takara Bio USA plans to invest $5,520,600.00 to build out 32,256 square feet of new space in San Jose. The company plans to occupy the new space at 2570 Orchard Pkwy in San Jose, on or about September 1, 2021. According to the company website For over 50 years, Takara Bio has been committed to helping scientists break new ground with our innovative technologies. Our extensive portfolio of reagents, instruments, and services support advancements in the life sciences, including frontline diagnostics and clinical applications. We are a part of Takara Bio Inc., a world leader in biotechnology research and development based out of Shiga, Japan. Our GMP manufacturing site in West Japan the first of its kind enables seamless and sterile handling of viruses, cells, and proteins. Our North America (NA) office is headquartered in Mountain View, CA, where we do most of our R&D, marketing, quality assurance, and ecommerce. Our other NA locations in Ann Arbor, MI, and Madison, WI, contribute to our research, logistics, and outreach programs. In addition, we have GMP stem cell facilities in Goteborg, Sweden, and the Takara Bio Europe headquarters in France that serves parts of Europe, the Middle East, and Africa.

To learn more about Takara Bio USA, visit http://www.takarabio.com/

Company Contact:
Koichi Nakao, Chief Executive Officer
800-662-2566

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved